Intravenous immunoglobulin inhibits antibody/complement-mediated demyelination

被引:0
|
作者
Harrer, M.
Fischer, K.
Goebels, N.
机构
[1] Univ Zurich, Zurich, Switzerland
[2] Univ Dusseldorf, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P682
引用
收藏
页码:S225 / S225
页数:1
相关论文
共 50 条
  • [1] Intravenous immunoglobulin completely inhibits demyelination in an antibody/complement-mediated model of CNS damage
    Harrer, M.
    Goebels, N.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S190 - S190
  • [2] Antibody and complement-mediated glial response and demyelination
    Berg, C.
    Khorooshi, R.
    Asgari, N.
    Linington, C.
    Morgan, P. B.
    Owens, T.
    GLIA, 2015, 63 : E361 - E362
  • [3] Modulation of complement-mediated tissue damage by intravenous immunoglobulin
    Basta, M
    INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 83 - 87
  • [4] Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination
    Storch, MK
    Piddlesden, S
    Haltia, M
    Iivanainen, M
    Morgan, P
    Lassmann, H
    ANNALS OF NEUROLOGY, 1998, 43 (04) : 465 - 471
  • [5] Intravenous immunoglobulin inhibits liposome-induced,complement-mediated hemodynamic changes in pigs and rats
    Basta, M
    Baranyi, L
    Savay, S
    Bodo, M
    Alving, CR
    Szebeni, J
    FASEB JOURNAL, 2000, 14 (06): : A957 - A957
  • [6] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN MODIFIES COMPLEMENT-MEDIATED INVIVO CLEARANCE
    BASTA, M
    LANGLOIS, PF
    MARQUES, M
    FRANK, MM
    FRIES, LF
    BLOOD, 1989, 74 (01) : 326 - 333
  • [7] COMPLEMENT-MEDIATED DEMYELINATION IN PATIENTS WITH IGM MONOCLONAL GAMMOPATHY AND POLYNEUROPATHY
    MONACO, S
    BONETTI, B
    FERRARI, S
    MORETTO, G
    NARDELLI, E
    TEDESCO, F
    MOLLNES, TE
    NOBILEORAZIO, E
    MANFREDINI, E
    BONAZZI, L
    RIZZUTO, N
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (10): : 649 - 652
  • [8] COMPLEMENT-MEDIATED DISSOCIATION OF ANTIBODY FROM ANTIGEN
    MILLER, GW
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1282 - 1282
  • [9] Antibody- and complement-mediated effector functions
    Luenemann, J.
    Bennett, J. L.
    Mantegazza, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 69
  • [10] COMPLEMENT-MEDIATED ALTERATION OF ANTIBODY SPECIFICITY INVIVO
    DRAKE, WP
    MARDINEY, MR
    JOURNAL OF IMMUNOLOGY, 1975, 114 (03): : 1052 - 1057